Natasha Darville
⚠️ High Risk
FEI: 3010075631 • Freeport City • BAHAMAS
FEI Number
3010075631
Location
Freeport City
Country
BAHAMASAddress
Tropical Carpet 8 Madeira Croft, , Freeport City, , Bahamas
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 4/19/2013 | 64BCY25HYDROCHLOROTHIAZIDE (DIURETIC) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 4/19/2013 | 61LCY38CLOPIDOGREL BISULFATE (ANTI-COAGULANT) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 4/19/2013 | 62OCY32FELODIPINE (ANTI-HYPERTENSIVE - PART II) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 4/19/2013 | 62OCA22CARVEDILOL (ANTI-HYPERTENSIVE - PART II) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 4/19/2013 | 64BCA27ISOSORBIDE (DIURETIC) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 4/19/2013 | 66FCA05COLCHICINE (SUPPRESSANT) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 4/19/2013 | 61JCA08ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 4/19/2013 | 62OCA14AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 4/19/2013 | 60LCA14CARBAMAZEPINE (ANALGESIC) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 4/19/2013 | 66TCA01ALLOPURINOL (XANTHINE OXIDASE INHIBITOR) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 4/19/2013 | 62CCY30HYDRALAZINE HCL (ANTI-HYPERTENSIVE) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
Frequently Asked Questions
What is Natasha Darville's FDA import refusal history?
Natasha Darville (FEI: 3010075631) has 11 FDA import refusal record(s) in our database, spanning from 4/19/2013 to 4/19/2013.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Natasha Darville's FEI number is 3010075631.
What types of violations has Natasha Darville received?
Natasha Darville has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Natasha Darville come from?
All FDA import refusal data for Natasha Darville is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.